Sara Nochur

Statistics

Publications

Citations

847

H-Index

Active since

1992

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

University of Tennessee Health Science Center

University of Colorado Denver

Medizinische Hochschule Hannover

St Vincent's Hospital Sydney

Sara Nochur is an author at Alnylam Pharmaceuticals (United States) specializing in viral respiratory infections, life sciences, and molecular virology.

Publications per year

1992–2015

Publications

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

John P. DeVincenzo, Rob Lambkin‐Williams, Tom Wilkinson et al. · Proceedings of the National Academy of Sciences · 2010 · 439 citations · Full text

Life Sciences, Infectious Diseases, Molecular Medicine +17

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

Martin R. Zamora, Marie Budev, Mark W. Rolfe et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 208 citations

Medicine, Infectious Diseases, Molecular Virology +16

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients

Jens Gottlieb, Martin R. Zamora, Tony N. Hodges et al. · The Journal of Heart and Lung Transplantation · 2015 · 161 citations

Medicine, Infectious Diseases, Molecular Virology +15

Mode of sugar phosphorylation inClostridium thermocellum

Sara Nochur, Gary R. Jacobson, Mary F. Roberts et al. · Applied Biochemistry and Biotechnology · 1992 · 26 citations

Life Sciences, Biochemistry, Microbiology +11

Abstract 67: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Results for ALN-PCS, a Novel RNAi Therapeutic for the Treatment of Hypercholesterolemia

Kevin Fitzgerald, Maria Frank-Kamenetsky, Timothy Mant et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 13 citations

Life Sciences, Pharmacokinetics, Pharmacology +17

1–5 of 5